These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 10022814

  • 1. Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells.
    Tari AM, Hung MC, Li K, Lopez-Berestein G.
    Oncogene; 1999 Feb 11; 18(6):1325-32. PubMed ID: 10022814
    [Abstract] [Full Text] [Related]

  • 2. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.
    Janes PW, Daly RJ, deFazio A, Sutherland RL.
    Oncogene; 1994 Dec 11; 9(12):3601-8. PubMed ID: 7970720
    [Abstract] [Full Text] [Related]

  • 3. Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells.
    Lim SJ, Lopez-Berestein G, Hung MC, Lupu R, Tari AM.
    Oncogene; 2000 Dec 14; 19(54):6271-6. PubMed ID: 11175341
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of the Ras activation pathway by MAP kinase phosphorylation of Sos.
    Buday L, Warne PH, Downward J.
    Oncogene; 1995 Oct 05; 11(7):1327-31. PubMed ID: 7478553
    [Abstract] [Full Text] [Related]

  • 5. Protein kinase A-Ialpha subunit-directed antisense inhibition of ovarian cancer cell growth: crosstalk with tyrosine kinase signaling pathway.
    Alper O, Hacker NF, Cho-Chung YS.
    Oncogene; 1999 Sep 02; 18(35):4999-5004. PubMed ID: 10490835
    [Abstract] [Full Text] [Related]

  • 6. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM, Breen K, Rødland MS, Haslekås C, Stang E, Madshus IH.
    Mol Cancer Res; 2009 Feb 02; 7(2):275-84. PubMed ID: 19208749
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of the Grb2 gene in human breast cancer cell lines.
    Daly RJ, Binder MD, Sutherland RL.
    Oncogene; 1994 Sep 02; 9(9):2723-7. PubMed ID: 8058337
    [Abstract] [Full Text] [Related]

  • 8. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
    Huang L, Watanabe M, Chikamori M, Kido Y, Yamamoto T, Shibuya M, Gotoh N, Tsuchida N.
    Oncogene; 2006 Oct 19; 25(49):6457-66. PubMed ID: 16702953
    [Abstract] [Full Text] [Related]

  • 9. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
    Zhang T, Ma J, Cao X.
    Biochem J; 2003 Dec 01; 376(Pt 2):457-64. PubMed ID: 14498832
    [Abstract] [Full Text] [Related]

  • 10. DDT stimulates c-erbB2, c-met, and STATS tyrosine phosphorylation, Grb2-Sos association, MAPK phosphorylation, and proliferation of human breast epithelial cells.
    Shen K, Novak RF.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):17-21. PubMed ID: 9070211
    [Abstract] [Full Text] [Related]

  • 11. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
    Huang Y, Li X, Jiang J, Frank SJ.
    Oncogene; 2006 Dec 07; 25(58):7565-76. PubMed ID: 16785991
    [Abstract] [Full Text] [Related]

  • 12. Association of Grb2 with Sos and Ras with Raf-1 upon gamma irradiation of breast cancer cells.
    Suy S, Anderson WB, Dent P, Chang E, Kasid U.
    Oncogene; 1997 Jul 03; 15(1):53-61. PubMed ID: 9233777
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS, Kapitonov D, O'Rourke DM.
    Cancer Res; 2004 Sep 15; 64(18):6444-52. PubMed ID: 15374953
    [Abstract] [Full Text] [Related]

  • 14. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.
    Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219
    [Abstract] [Full Text] [Related]

  • 15. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG.
    Oncogene; 2002 Jan 17; 21(3):460-74. PubMed ID: 11821958
    [Abstract] [Full Text] [Related]

  • 16. Epidermal growth factor receptor transcriptionally up-regulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway involving phosphatidylinositol 3'-kinase and distinct from that induced by hypoxia.
    Maity A, Pore N, Lee J, Solomon D, O'Rourke DM.
    Cancer Res; 2000 Oct 15; 60(20):5879-86. PubMed ID: 11059786
    [Abstract] [Full Text] [Related]

  • 17. Dominant-negative mutants of the SH2/SH3 adapters Nck and Grb2 inhibit MAP kinase activation and mesoderm-specific gene induction by eFGF in Xenopus.
    Gupta RW, Mayer BJ.
    Oncogene; 1998 Oct 29; 17(17):2155-65. PubMed ID: 9811447
    [Abstract] [Full Text] [Related]

  • 18. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
    Tuck AB, Hota C, Wilson SM, Chambers AF.
    Oncogene; 2003 Feb 27; 22(8):1198-205. PubMed ID: 12606946
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB, Hynes NE, Lane HA.
    Cancer Res; 2002 Jun 01; 62(11):3151-8. PubMed ID: 12036928
    [Abstract] [Full Text] [Related]

  • 20. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway.
    Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B.
    Nat Cell Biol; 2001 May 01; 3(5):527-30. PubMed ID: 11331884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.